Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence of PMS-induced ovulation in the immature rat. I. Catecholamine turnover changes in relation to the critical period.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology*; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D007031:Hypothalamus / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood; D008473:Median Eminence / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010060:Ovulation / Q000187:drug effects; D011301:Preoptic Area / Q000378:metabolism*; D051381:Rats; D012741:Sexual Maturation / Q000187:drug effects; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D002395:Catecholamines; D006064:Gonadotropins, Equine; D007986:Luteinizing Hormone; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine; D009638:Norepinephrine